ctrl K

Price Alert

CollPlant Biotechnologies... (CLGN)

NASDAQ: CLGN · Real-Time Price · USD

2.40

-0.26 (-9.77%)

At close: Aug 19, 2025, 3:59 PM

2.46

2.50%

After-hours: Aug 19, 2025, 05:42 PM EDT

CollPlant Biotechnologies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.91M	26.67M	29.65M	13.15M
Short-Term Investments	n/a	n/a	n/a	30.15M
Long-Term Investments	n/a	n/a	188K	213K
Other Long-Term Assets	118K	57K	188K	213K
Receivables	583K	393K	9K	270K
Inventory	440K	714K	1.43M	1.08M
Other Current Assets	248K	241K	566K	437K
Total Current Assets	13.18M	28.02M	31.66M	45.09M
Property-Plant & Equipment	5.28M	5.86M	5.68M	5.68M
Goodwill & Intangibles	131K	188K	245K	243K
Total Long-Term Assets	5.53M	6.1M	6.11M	6.14M
Total Assets	18.71M	34.13M	37.77M	51.22M
Account Payables	870K	980K	1.13M	1.03M
Deferred Revenue	n/a	n/a	n/a	32K
Short-Term Debt	n/a	n/a	529K	519K
Other Current Liabilities	1.19M	1.54M	-30K	47K
Total Current Liabilities	2.97M	3.25M	3.1M	3.01M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.27M	2.54M	2.38M	3.09M
Total Liabilities	5.25M	5.79M	5.49M	6.1M
Total Debt	3.08M	3.16M	2.91M	3.61M
Common Stock	4.98M	4.98M	4.87M	4.66M
Retained Earnings	-113.35M	-96.74M	-89.72M	-72.8M
Comprehensive Income	-969K	-969K	-969K	-969K
Shareholders Equity	13.46M	28.34M	32.28M	45.12M
Total Investments	n/a	57K	188K	30.15M